Geneva Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104M Sell
1,149,680
-24,390
-2% -$2.07M 2.38% 10
2026
Q1
$98.1M Buy
1,174,070
+55,494
+5% +$4.55M 2.09% 13
2025
Q4
$102M Buy
1,118,576
+20,969
+2% +$2.01M 1.93% 16
2025
Q3
$104M Sell
1,097,607
-10,634
-1% -$1M 1.78% 16
2025
Q2
$116M Buy
1,108,241
+64,487
+6% +$6.11M 1.94% 16
2025
Q1
$92.2M Sell
1,043,754
-5,149
-0.5% -$528K 1.72% 18
2024
Q4
$101M Buy
1,048,903
+206,894
+25% +$19.3M 1.75% 19
2024
Q3
$68.9M Buy
842,009
+640
+0.1% +$49.4K 1.15% 30
2024
Q2
$72.5M Sell
841,369
-24,197
-3% -$1.96M 1.32% 27
2024
Q1
$70.7M Sell
865,566
-5,169
-0.6% -$404K 1.24% 28
2023
Q4
$57.7M Sell
870,735
-5,613
-0.6% -$389K 1.09% 32
2023
Q3
$64M Buy
876,348
+2,535
+0.3% +$171K 1.35% 28
2023
Q2
$55.2M Sell
873,813
-7,608
-0.9% -$441K 1.09% 34
2023
Q1
$51.7M Buy
881,421
+13,623
+2% +$827K 1.05% 34
2022
Q4
$53.5M Sell
867,798
-8,893
-1% -$598K 1.2% 29
2022
Q3
$58.9M Buy
876,691
+26,414
+3% +$1.67M 1.36% 26
2022
Q2
$52.2M Sell
850,277
-7,641
-0.9% -$489K 1.2% 31
2022
Q1
$57.9M Buy
857,918
+36,520
+4% +$1.97M 1.12% 32
2021
Q4
$36.3M Sell
821,398
-66,492
-7% -$3.87M 0.59% 72
2021
Q3
$57.5M Sell
887,890
-170,642
-16% -$11.9M 0.97% 38
2021
Q2
$85.2M Sell
1,058,532
-25,675
-2% -$1.96M 1.39% 20
2021
Q1
$73.7M Sell
1,084,207
-23,116
-2% -$1.82M 1.26% 28
2020
Q4
$77.2M Sell
1,107,323
-20,310
-2% -$1.26M 1.31% 24
2020
Q3
$57.9M Buy
1,127,633
+743
+0.1% +$40.8K 1.19% 27
2020
Q2
$66.1M Buy
1,126,890
+17,652
+2% +$976K 1.43% 19
2020
Q1
$56.1M Buy
+1,109,238
New +$73.7M 1.6% 10

Other funds holding HQY

Geneva Capital Management's HQY Position: Q2 2026 in Review

Geneva Capital Management reduced its HealthEquity (HQY) stake by 2.1% in Q2 2026, selling an estimated $2.07M and leaving 1,149,680 shares worth $104M. The position accounts for 2.38% of the portfolio, ranked #10.

Geneva Capital Management first reported a position in HQY in Q1 2020 and has held it in 26 quarters since. The position peaked at $116M in Q2 2025. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Geneva Capital Management held 1,149,680 shares of HealthEquity worth $104M as of Q2 2026.
  • Geneva Capital Management sold 24,390 HealthEquity shares in Q2 2026, an estimated $2.07M.
  • HealthEquity made up 2.38% of Geneva Capital Management's portfolio in Q2 2026, its #10 holding.
  • Geneva Capital Management first reported a position in HealthEquity in Q1 2020 and has held it in 26 quarters since.
  • Geneva Capital Management's HealthEquity position peaked at $116M in Q2 2025.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.